Clinical Trial Update: Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effectiveness of Hemopatch, a hemostatic patch, in patients undergoing liver resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Liver Damage
• Liver Disease
• Liver Surgery

Drugs mentioned

• Hemopatch

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Liver Damage, Surgery | Phase 3 | Status: UNKNOWN